As on Thursday, AN2 Therapeutics Inc (NASDAQ: ANTX) got off with the flyer as it spiked 20.00% to $1.32, before settling in for the price of $1.1 at the close. Taking a more long-term approach, ANTX posted a 52-week range of $1.00-$1.55.
The Healthcare sector firm’s twelve-monthly sales growth has been -41.25% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was -41.25%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 34.88%. This publicly-traded company’s shares outstanding now amounts to $27.37 million, simultaneously with a float of $15.35 million. The organization now has a market capitalization sitting at $36.17 million. At the time of writing, stock’s 50-day Moving Average stood at $1.1357, while the 200-day Moving Average is $1.1733.
AN2 Therapeutics Inc (ANTX) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. AN2 Therapeutics Inc’s current insider ownership accounts for 43.99%, in contrast to 29.03% institutional ownership. According to the most recent insider trade that took place on Jan 06 ’26, this organization’s Chief Financial Officer sold 5,512 shares at the rate of 1.01, making the entire transaction reach 5,578 in total value, affecting insider ownership by 75,363. Preceding that transaction, on Jan 05 ’26, Company’s Chief Financial Officer sold 3,295 for 1.00, making the whole transaction’s value amount to 3,305. This particular insider is now the holder of 80,875 in total.
AN2 Therapeutics Inc (ANTX) Earnings and Revenue Records
AN2 Therapeutics Inc’s EPS increase for this current 12-month fiscal period is 34.88% and is forecasted to reach -0.91 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 22.52% through the next 5 years, which can be compared against the -41.25% growth it accomplished over the previous five years trading on the market.
AN2 Therapeutics Inc (NASDAQ: ANTX) Trading Performance Indicators
Let’s observe the current performance indicators for AN2 Therapeutics Inc (ANTX). It’s Quick Ratio in the last reported quarter now stands at 9.33.
In the same vein, ANTX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.13, a figure that is expected to reach -0.24 in the next quarter, and analysts are predicting that it will be -0.91 at the market close of one year from today.
Technical Analysis of AN2 Therapeutics Inc (ANTX)
Through scrutinizing the latest numbers posted by the [AN2 Therapeutics Inc, ANTX], it can be observed that its last 5-days Average volume of 0.28 million was better the volume of 0.28 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 66.43% While, its Average True Range was 75.53.
Raw Stochastic average of AN2 Therapeutics Inc (ANTX) in the period of the previous 100 days is set at 76.19%, which indicates a major fall in contrast to 91.45% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.0905 that was higher than 0.0733 volatility it exhibited in the past 100-days period.
